J.McDermottC
I think because these side effects are notable and even perhaps more than is generally recognized as you're bringing up, the concern here is without a exit ramp, we got a lot of potential lurking trouble there
Washington is spending $250,000 to study a prescription drug benefit that includes FDA-approved weight-loss medications
This, however, does not apply to other GLP-1RAs approved for the treatment of T2DM, including the same liraglutide (Victoza) and semaglutide (Ozempic or Rybelsus) at lower dosages, prompting several stakeholders to request an updated guidance 232 and more caution in media enthusiasm 233
Ellis, R
Individuals using GLP-1 medications may experience: Reduced caloric and protein intake Early satiety or nausea Gastrointestinal changes that affect absorption Increased fatigue during metabolic adjustment Because B-complex vitamins support energy metabolism, neurological pathways, and gastrointestinal integrity, supportive supplementation may be considered when intake is reduced or oral tolerance is limited
